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23 
Abstract (248 words) 24 
Purpose: This study aimed at characterising A. baumannii strains isolated from patients in 25 
ICU setting using molecular techniques to study clonal relatedness to determine a fast, 26 
efficient and a cost effective way of detecting persistent clones. 27 
Methodology: A. baumannii (n=17) were obtained in June and November 2015 from a single 28 
ICU setting in South India. DNA typing methods such as MLST, SBT and DNA fingerprinting 29 
PCRs (M13, DAF4, ERIC2) were employed to understand the association of clones. PCR for 30 
antimicrobial resistance genes ISAba1-blaOXA-51-like, ISAba1-blaOXA-23-like, blaNDM-1, blaPER-7, 31 
blaTEM-1 and virulence genes cpa 1, cpa 2 and pkf were performed.  32 
Results: The MLST showed some degree of corroboration with other DNA typing methods 33 
such as SBT and M13, DAF4, ERIC2. M13 PCR was found to give better results than other 34 
fingerprinting methods. ST848 (CC92) was the dominant strain isolated in both June and 35 
November. All isolates were blaOXA-51-like positive with 16 having ISAba1 upstream of blaOXA-36 
51-like and blaOXA-23-like genes. Genes such as blaNDM-1 (23%, n= 4), blaPER-7 (58.8%, n= 10), pkf 37 
(82%, n= 14), blaTEM-1 (5.8%, n=1), cpa 1 (5.8%, n=1) and cpa 2 (5.8%, n=1) were also 38 
detected. 39 
Conclusion: M13 PCR can be used in routine environmental surveillance for detection of 40 
persistent antibiotic resistant clones in an ICU setting because of its reliability and simplicity. 41 
Further studies based on greater sample size, conducted at multi-centre level can give a 42 
better understanding on the reliability of molecular methods which can be used for 43 
detection of persistent clones in hospital setting. 44 
  45 
Introduction: 46 
Nosocomial infections are a major problem for immunocompromised patients, increasing 47 
mortality and morbidity rates, even in a specialized and well-equipped hospital 48 
environment. The main cause of nosocomial infections is bacterial drug resistance to various 49 
antimicrobial agents and the difficulty in eradicating them. Acinetobacter baumannii is an 50 
opportunistic pathogen of clinical significance which causes various hospital and 51 
community-acquired infections such as pneumonia, urinary tract infection, suppurative 52 
infection and bloodstream infections [1]. It is not only emerging as a cause of numerous 53 
global outbreaks but also has increasingly high rates of resistance which makes treatment 54 
difficult for severely ill patients that need hospitalisation [2–4]. The frequency by which the 55 
intubated patient acquires A. baumannii infection is around 58% compared to 30% which is 56 
caused by other Gram-negative bacteria [5].  57 
The most important mechanisms through which A. baumannii can acquire resistance are: 58 
presence of intrinsic antimicrobial resistance (AMR) genes such as oxacillinases, insertion 59 
sequences like ISAba1 which help in mobilisation of such genes and control their [6, 7]. 60 
Virulence genes such as serine protease (pkf) which degrades the essential complement 61 
components like C3 and endopeptidases (cpa1 and cpa2) which disrupt the common 62 
mechanism of coagulation, help the organism to prevail and disseminate in the hospital 63 
setting [8, 9]. Resistance Nodulation Division (RND) family efflux pumps genes such as 64 
adeABC, adeIJK and adeFGH also play an important role in the emergence of  resistant A. 65 
baumannii strains [10]. 66 
The exact mode of transmission may not be known, because the isolation of A. baumannii 67 
strains in environmental surveillance cultures is not so frequent which makes eradication of 68 
this organism very difficult in the hospital setting but it can be prevented by implementing 69 
good clinical practises and effective infection control measures [11–14].  Most of the studies 70 
consistently report on the nosocomial infection caused by A. baumannii. The hospital 71 
outbreaks and nosocomial infection by A. baumannii has been attributed to their increase 72 
antibiotic resistance, virulence and their ability to survive on inanimate and dry surface [4, 5, 73 
9, 10]. To understand more about the spread and epidemiology of A. baumannii in a 74 
hospital setting many molecular based methods have been employed. They can be broadly 75 
classified as 1) PCR-based DNA fingerprinting techniques (M13, ERIC, DAF4) 2) Restriction 76 
enzyme based (AFLP, RFLP and PFGE) 3) Sequence based (Single locus sequence based 77 
typing) 4) Single nucleotide polymorphism based on analyses of whole genome and 5) Multi 78 
locus sequence typing (MLST) [15]. The main aim of this study was to identify and track the 79 
circulating clonal types of A. baumannii in an Intensive care unit (ICU) setting to detect the 80 
mode of transmission between the patients in the months of June and November of 2015 81 
using molecular techniques such as MLST, SBT and DNA fingerprinting PCRs. This project 82 
also compares the efficacy of the molecular techniques based on cost, time and its effective 83 
usage in routine surveillance to identify circulating clonal types in hospital setting. 84 
Materials and Methods: 85 
Bacterial isolates: 86 
Acinetobacter baumannii isolates were obtained from a tertiary care hospital, in South India, 87 
in June, 2015 (AB01-AB12) and November, 2015 (AB13 to AB 17) (Table S1).  All isolates 88 
were from the same ICU setting and were either multidrug resistant (resistant to more than 89 
three classes of antibiotics) or extensively drug resistant (susceptible to two or less than two 90 
classes of antibiotics)[16]. The isolates were from blood and endotracheal aspirate (ETA). In 91 
case of ETA isolates there were 3 inclusion criteria: The patient sample should have more 92 
than 105 CFU/ml of organisms, the pus cells should be moderate or more and radiological 93 
features must suggest ventilator associated pneumonia. Isolates which fulfilled at least two 94 
criteria were selected (Table S1).  All the isolates were identified as Acinetobacter 95 
baumannii using PCR amplification of blaOXA-51-like gene and confirmed by sequencing of rpoB 96 
gene [17–19].  97 
Antimicrobial Susceptibility Testing: 98 
Susceptibility pattern to different classes of antimicrobials were determined by standard 99 
disc diffusion method. The results were interpreted according to Clinical Laboratory 100 
Standard Institute guidelines [20, 21]. The antimicrobials used for disc diffusion 101 
susceptibility testing were ceftazidime (30 µg), cefepime (30 µg), piperacillin/tazobactam 102 
(100/10 µg), cefoperazone/sulbactam (75/30 µg), amikacin (30 µg), netilmicin (30 µg), 103 
tobramycin (10 µg), aztreonam (30µg), levofloxacin (5 µg), tetracycline (30 µg), 104 
trimethoprim/sulfamethoxazole (1.25/23.75 µg), imipenem (10 µg) and meropenem (10 µg). 105 
Minimum inhibitory concentration (MIC) by broth micro dilution (BMD) for polymyxin B and 106 
polymyxin E were performed for all clinical isolates of A. baumannii as per the CLSI 107 
guidelines. A. baumannii ATCC 19606 was used as the control strain. 108 
CarbAcineto NP: 109 
CarbAcineto NP test was performed for the phenotypic assessment of carbapenemase 110 
activity for all A. baumannii strains [22].  The carbapenemase activity was detected by 111 
colour change from red to yellow, which results by the hydrolysis of imipenem leading to 112 
decrease in pH value. Strains BAA-1705 (blaKPC positive) and BAA-1706 (carbapenemase 113 
negative) were included as positive and negative controls. 114 
PCR for the detection of carbapenemase genes: 115 
DNA extraction was performed using automated Qiagen QiaSymphony system as per the 116 
manufacturer’s instructions [23].  Multiplex PCR for the detection of OXA classes of enzymes 117 
was performed as described earlier by Woodford et al [24]. A multiplex PCR was also 118 
performed to detect extended spectrum β-lactamases (ESBL) genes such as blaTEM, blaSHV, 119 
blaGES, blaPER, blaVEB and class A carbapenemase blaKPC and for the detection of blaIMP, blaVIM, 120 
blaSIM, blaNDM, and blaSPM metallo β-lactamases [25–28].   121 
In order to detect allelic variants of genes, primers (Table S2) were designed using BioEdit 122 
(http://www.mbio.ncsu.edu/BioEdit/page2.html) and NCBI gene sequences. PCR was 123 
performed using Veriti thermal cycler, Applied Biosystem. The cycling conditions were: 124 
initial denaturation at 94 °C for 15 min, 35 cycles of 94 °C for 30 sec, 54 °C for 30 sec, 72 °C 125 
for 45 sec, followed by final extension at 72 °C for 10 min. The amplified products were 126 
sequenced using AB - Applied Biosystem 3130 - Genetic Analyser and then the sequence 127 
information was analysed and translated into amino acid sequences using BioEdit software. 128 
The translated information was used for blastp analysis using the Protein Basic Local 129 
Alignment Search Tool available through NCBI [29]. 130 
Detection of insertion element associated with OXA51 and OXA23: 131 
To detect the presence of insertion sequence (IS) ISAba1, PCR was first performed using 132 
primers described by Turton et al [30]. Also, mapping of ISAba1 element relative to blaOXA-23-133 
like and blaOXA-51-like genes was accomplished. In case of blaOXA-23-like, forward primer of ISAba1 134 
with reverse of blaOXA-23-like and reverse of ISAba1 with forward primer of blaOXA-23-like was 135 
used, while in blaOXA-51-like, FxOxa forward primer described by Lopes et al. (2011) and 136 
reverse of blaOXA-51-like were used (Table S2)[7, 24]. 137 
For mapping blaOXA-51-like, Qiagen Phusion high fidelity PCR master mix from New England Bio 138 
labs was used. The reaction mix consisted of 2 µl of template DNA, 10 µl of Phusion master 139 
mix, 1 µl each of forward and reverse primer (10 pM), 0.6 µl DMSO and 5.4 µl of molecular 140 
grade water. The cyclic conditions for blaOXA-51-like mapping were; initial denaturation at 95°C 141 
for 2 minutes, 35 cycles of 95°C for 10 secs, 57°C for 30 secs, 72°C for 30 secs, followed by 142 
final extension at 72°C for 10 minutes. For mapping of ISAba1-blaOXA-23-like Qiagen HotStart 143 
PCR master mix was used. The reaction mix consisted of 2 µl of template DNA, 10 µl of 144 
HotStart master mix, 1 µl each of forward and reverse primer (10 pM) and 6 µl of molecular 145 
grade water. The cycling conditions were; initial denaturation at 95°C for 15 minutes, 35 146 
cycles of 95°C for 30 secs, 56°C for 45 secs, 72°C for 1 minute followed by final extension at 147 
72°C for 10 minutes. 148 
PCR for detection of virulence genes: 149 
PCR was performed to detect serine protease gene pkf and zinc-dependent metallo-150 
endopeptidase genes cpa1 and cpa2 in this study (Table S2). The reaction mix consisted of 2 151 
µl of template DNA, 10 µl of Qiagen HotStart master mix, 1 µl each of forward and reverse 152 
primer (10pm) and 6 µl of molecular grade water. The cycling conditions for pkf, cpa1 and 153 
cpa2 were as follows: initial denaturation at 95°C for 15 minutes, 35 cycles of 95°C for 45 154 
secs, 52°C for 45 secs, 72°C for 2 minutes, followed by final extension at 72°C for 10 155 
minutes. 156 
Multilocus sequence typing: 157 
All A. baumannii isolates were subjected to MLST analysis using the Oxford scheme with 158 
primers and conditions described previously by Bartual et al [31]. The amplicons were 159 
purified using Magbio kit (Gaithersberg, US) and sequenced using the AB - Applied 160 
Biosystem 3130- Genetic Analyser. The sequences obtained were trimmed using FinchTV 161 
and BioEdit. After trimming the sequence were submitted in PubMLST data base and 162 
Sequence types (STs) were assigned. New STs and allele numbers were assigned by 163 
submitting the data to the curator of A. baumannii in MLST database. The clonal complexes 164 
(CCs) were established using the eBURST software (http://eburst.mlst.net/)[32]. 165 
Single-locus sequence based typing: 166 
Another technique used for distinguishing A. baumannii is single-locus sequence based 167 
typing of blaOXA-51- like which is an intrinsic class D beta-lactamase gene in this species [33]. 168 
The blaOXA-51-like variants were analysed using the Oxa 51F and Oxa 51R primers (Table S2). 169 
The cycling condition used were; Initial denaturation at 95°C for 15 minutes, 35 cycles of 170 
95°C for 1min, 50°C for 2min, 72°C for 3min, followed by final extension of 72°C for 10 171 
minutes. The amplicons were purified using Magbio kit and sequenced using the ABI- 172 
applied biosystem 3130- genetic analyser sequencing. The sequences obtained were 173 
trimmed and translated to their respective protein sequence using BioEdit. The translated 174 
sequence was blasted in NCBI using protein blast tool (blastp) to detect blaOXA-51-like variants.         175 
PCR based DNA fingerprinting: 176 
DNA fingerprinting analyses were performed using ERIC2, 5’-177 
AAGTAAGTGACTGGGGTGAGCG-3’, M13, 5’-GAGGGTGGCGGTTCT-3’ and  DAF4, 5’-178 
CGGCAGCGCC-3’ primers as described earlier [34]. Primers M13 and DAF4 target conserved 179 
sequences, while primer ERIC-2 targets enterobacterial repetitive sequences [34]. Slight 180 
modifications were done in the cycling condition to obtain optimal product amplification, 181 
initial denaturation was performed at 95°C for 15 mins, followed by 35 cycles of 95°C for 1 182 
min, 50°C for 2 mins, 72°C for 3mins, and final extension of 72°C for 10 mins for all three 183 
primer sets.  184 
 185 
Cluster analysis was performed using the unweighted pair group method with mathematical 186 
averages, and relatedness was calculated using the band-based Dice coefficient with a 1.5% 187 
band tolerance and 1.5% optimisation setting for the whole profile using BIONUMERICS v7.6 188 
software (Applied Maths, Sint-Martens-Latem, Belgium). A value of 85% was chosen as the 189 
threshold for the establishment of clonal relatedness of the strains [35]. 190 
 191 
  192 
Results: 193 
Antimicrobial Susceptibility Testing:  194 
All isolates except AB17 were resistant to 7 classes of antimicrobials including; amikacin, 195 
aztreonam, ceftazidime, ciprofloxacin, imipenem, levofloxacin, meropenem, netilmicin, 196 
piperacillin/tazobactam, sulbactam, tobramycin, trimethoprim/ sulfamethoxazole. For 197 
carbapenem resistance the AST data was well supported by CarbAcineto NP which gave 198 
positive result for 94% (n=16) of the isolates. This test had 100% sensitivity (95%CI: 79.41% 199 
to 100.00%) and 100% specificity (2.50% to 100.00%). In case of colistin all isolates were 200 
susceptible, whereas for tigecycline and tetracycline the resistance was seen in 70% (n = 12) 201 
and 35% (n = 6) of isolates. 202 
Antimicrobial resistance genes:  203 
The intrinsic oxacillinase gene blaOXA-51-like was found in all 17 isolates of which 15 isolates 204 
were positive for ISAba1-blaOXA-23-like constituting a Tn2008 while one isolate had ISAba1-205 
blaOXA-23-like-ISAba1 constituting a Tn2006 transposon. The blaNDM-1 metallo β-lactamases was 206 
detected in 23.5% (n=4) isolates, other genes such as blaKPC, blaIMP, blaVIM, blaSIM, blaSPM, 207 
blaOXA-24-like and blaOXA-58-like could not be detected. 35.2% of the isolates (n=6) were negative 208 
for tested ESBL encoding gene while blaPER-7 was present in 58.8% of isolates (n=10) and 209 
blaTEM-1 gene in 1 isolate (Table 1). The blaSHV, blaVEB and blaGES genes were not identified in 210 
any isolates. ISAba1 element was present in all the isolates but in 94.1% of isolates (n=16), 211 
this element was found upstream of blaOXA-51-like gene (Table 1). Among the 17 isolates 212 
tested, 14 isolates (82.3%) were positive for proteinase kinase F (pkf) and one isolate 213 
positive for both cpa1 and cpa2 coagulation dependent metallo-endopeptidase (Table 1). 214 
Multilocus and Single-locus sequence based typing: 215 
Among the STs identified by MLST (Oxford scheme), five were novel and assigned as ST1305, 216 
ST1306, ST1307, ST1308 and ST1335 and were identified in five isolates. Other known 217 
strains, ST1114, ST391 and ST218 were detected in three isolates. ST848 strain was detected 218 
in 5 isolates in both June and November months, followed by ST862 identified in 2 isolates 219 
and ST195 in 2 isolates. (Table 1). The eBURST analyses of our strains with all identified STs 220 
in MLST database showed that ST195, ST218, ST848, ST1114, ST1305 belonged to CC92, 221 
whereas ST391 belonged to CC391 and ST862, ST1306, ST1308 belonged to CC862, whereas 222 
ST1307 and ST1335 were singletons (Figure 1). SBT was carried out for all 17 isolates of 223 
which 11 isolates carried the blaOXA-66 variant, 3 isolates were blaOXA-104 positive, 3 isolates 224 
were positive for one of the OXA-variant, blaOXA-68, blaOXA-144 or blaOXA-343. 225 
PCR based DNA fingerprinting: 226 
Of the three different primer sets, M13 primer generated distinct fingerprint patterns, with 227 
only a relatively small number of secondary faint bands (Figure 2). All DNA fingerprinting 228 
methods generated at least 9 distinct clusters in which isolates could be grouped. Using the 229 
DAF4 primer seven isolates (cluster 1) grouped together of which five ST848 (CC92, OXA-66) 230 
isolates clustered together in the ERIC2 (cluster 4) and M13 (cluster 6) fingerprint profiles 231 
(Figure 2). The results obtained by MLST indicate that ST848 (n=5) isolates were isolated in 232 
the months of June (n=3) and November (n=2). It can be seen that ST848 isolates harbouring 233 
OXA-66 are clonal in nature as they clustered together in all of the three typing methods 234 
with 100% similarity pattern in case of DAF4 and M13 PCRs whereas 85% similarity in case 235 
of ERIC PCR. The timeframe indicates that this clone persisted over time from June as it was 236 
also observed in November. It can be said that ST862 isolates are different clones as one 237 
strain has OXA-144 (AB12, June 2016) and the other has OXA-104 (Ab14, November 2016), 238 
further analyses using whole genome MLST can provide a better understanding on the 239 
evolution and stability of these strains. AB14 isolate was a ST862 strain whereas AB15 had 240 
ST1335 strain type. These two strains have differences in 3 housekeeping genes (Oxford 241 
MLST scheme) when compared to each other and M13 PCR rightly indicates that they are 242 
related but not identical to each other as opposed to DAF4 and ERIC PCR which cluster these 243 
two isolates at 100% similarity level. AB5 (ST218) and AB8 (ST195) had 1 allele difference at 244 
the MLST level and clustered well with DAF4 and ERIC PCR as opposed to M13 PCR. Similar 245 
clustering was also seen in the case of AB1 (ST1305) and AB3 (ST1306) but all 7 alleles were 246 
different and strains belonged to different clonal complexes. So different DNA fingerprinting 247 
techniques can often give different results which need to be supplemented with other 248 
genotypic and sequence based data for understanding the spread and persistence of clones 249 
in hospital settings. 250 
  251 
Discussion: 252 
Restriction and hybridisation based techniques like ribotyping and Pulsed-Field Gel 253 
electrophoresis (PFGE) though have moderate – high relative discriminatory power, relative 254 
reproducibility and repeatability; they are laborious and more time consuming not so cost 255 
effective for routine surveillance in low income countries and requires special technical skills 256 
such as DNA plug preparation and handling [15]. Multi-locus sequence typing (MLST) has a 257 
high discriminatory power whereas Next generation sequencing (NGS) has a very high 258 
discriminatory power but as these techniques involve multiple steps such as PCRs of 259 
housekeeping gene and sequencing in case of MLST and library preps, genome assemblies 260 
for NGS. MLST is a good epidemiological tool for global tracking of clones as opposed to 261 
PFGE which is reliably detects hospital outbreaks and is useful in strain tracking related to 262 
persistent hospital clones [31]. 263 
In a recent study, wgMLST (whole genome Multi Locus Sequence Typing) was regarded as 264 
the best approach for real-time surveillance as it delivers optimal resolution and 265 
epidemiological concordance while providing unambiguous nomenclature [36]. The Single 266 
locus based typing (SBT) which involves amplifying and sequencing blaOXA-51-like gene of A. 267 
baumannii provides some advantage over MLST as it involves amplification and sequencing 268 
of just one gene as opposed to seven and is said to distinguish all epidemic and sporadic 269 
lineages of A. baumannii strains on par with MLST. Based on the findings of Pournaras et al 270 
[33], SBT should correlate well with MLST but in our study it gave discrepant results where 271 
blaOXA-66 (AB03), blaOXA-104 (AB14) and blaOXA-144 (AB12) clustered in a single clonal complex 272 
862 (Table 1) and hence using SBT data alone can often lead to misinterpretation of the 273 
results in order to distinguishing clones of A. baumannii. The clonal complex of strains in 274 
comparison to the blaOXA-51-like variants showed good correlation. Hence, it can be said that 275 
SBT can give some information about the clone type and its association with Global Clones 276 
1-8 but this has to be supplemented with other methods such as M13 PCR, PFGE, MLST or 277 
whole genome MLST to reliably interpret the results. 278 
Typing methods such as Rapid Amplified Polymorphic DNA (RAPD) typing (using M13, DAF4 279 
primers) and repetitive extragenic palindrome (rep) PCR typing are simple and easy to 280 
perform and can provide an effective alternative in understanding the epidemiology of 281 
strains in resource limited countries as on most occasions they are reliable, less 282 
complicated, rapid and cost effective [37]. Although it can have some disadvantages such as 283 
low reproducibility between the labs but this can be standardised for usage within the same 284 
lab [15]. With the three DNA fingerprinting methods such as M13, ERIC-2 and DAF4, we 285 
observed that each technique produced a unique DNA fingerprint but M13 PCR was slightly 286 
more reproducible with distinct bands than others and had a higher discriminatory power 287 
than ERIC-2 and DAF-4 PCR techniques. Though the reproducibility of M13 technique may 288 
be quiet low between laboratories due to several factors such as standardisation of 289 
template concentration, use of PCR kits or enzymes used in reaction, thermocyclers and PCR 290 
conditions [38], but within a single setting it can prove to effective in detecting persistent 291 
clones that are may be difficult to detect in routine environmental surveillance where 292 
environmental surveillance fails in detection of clones [34]. We also observed that M13 PCR 293 
also had a higher discriminatory power than MLST and SBT (Figure 2), but small sample size 294 
and using MLST as the gold standard was a limitation of our study. It has also been shown 295 
previously that rep-PCR (ERIC) may prove to be less discriminatory between strains as a 296 
result of repeated independent DNA preparations or DNA quality [39]. MLST data showed 297 
that isolates belonging to Global clone 2 (GC2) (CC92 -Oxford scheme) found to occur in 298 
Asian countries and also in the Tamil Nadu region of South India was also the most 299 
prevalent clone in our study [40, 41]. On the contrary Global clone 1 (GC1) which 300 
corresponds to CC108 and found to be more prevalent in India was not observed in our 301 
study [40, 41]. 302 
The secondary finding of our study was detection of carbapenem resistance in A. baumannii. 303 
Previous studies on ESBLs have demonstrated, blaPER was common and blaTEM was rarely 304 
detected in A. baumannii [42, 43]. Similarly, in this study, blaPER-7 was detected in 10 305 
isolates, whereas blaTEM-1 was found in only one isolate. It is indeed possible that the blaPER-7 306 
gene could have been plasmid associated as observed by Opazo et al but this was not tested 307 
in the present study [43]. Pathogens that produce carbapenemase along with ESBL can be 308 
particularly challenging for clinicians to treat, since they are resistant to antibiotics of 309 
different classes [25]. In the present study, most of the isolates were positive for ISAba1 and 310 
this element was also detected upstream of the blaOXA-51-like and blaOXA-23-like genes which 311 
suggests that carbapenem resistance may be due to the overexpression of blaOXA-51-like and 312 
blaOXA-23-like genes [30]. In one isolate (AB03, ST1306 isolated from blood and ETA of the 313 
same patient), the blaOXA-23-like was bracketed by two copies of ISAba1 forming a composite 314 
transposon (Tn2006) which has the potential to mobilise OXA-23 gene in different strains of 315 
A. baumannii [44]. Tn2006 occurring in different genotypic variants of A. baumannii is often 316 
associated with higher mortality [45] and this was true in the case of this patient who 317 
succumbed to his injuries during the course of this study.  318 
The once predominant dogma that described antibiotic resistance and fitness as an inverse 319 
relationship may not hold true for Gram negative bacteria such as Pseudomonas where 320 
increased virulence is associated with increased resistance to polymyxin B, gentamicin and 321 
ciprofloxacin as a result of swarming motility but this dogma holds true for bacteria such as 322 
A. baumannii [46].  The cpa gene known for degrading the coagulation factors like Factor V 323 
and fibrinogen, thus interfering with contact-activated clot formation in human plasma, a 324 
process which is required for effective innate immune defence during A. baumannii 325 
infection was observed in one isolate in our study [9]. By this disruption of the common 326 
pathway of coagulation the bacterial pathogens can promote bleeding and dissemination 327 
during infection in debilitated patients. Most of our isolates were positive for pkf, a serine 328 
protease responsible for degrading essential complement compounds such as C3 and 329 
complement regulators like properdin contributing to serum resistance and reduce biofilm 330 
formation, possibly by preventing steps involved in initial attachment. PKF plays an 331 
important role in A. baumannii serum resistance by the cleavage of complement 332 
components, leading to the dissociation of the cascade and subsequent survival of the 333 
bacterium [8]. A. baumannii shows pathology most often to patients who are severely 334 
immunocompromised, thus inactivation of the complement immune defence could allow an 335 
onset of fulminating infection. Proteases cleave proteins involved in cell-to-cell adhesion, 336 
which often results in dispersal of bacteria from a biofilm [47]. A. baumannii may be able to 337 
regulate its behaviour in a host by forming biofilm during optimal conditions or by producing 338 
PKF to inhibit biofilm formation when it would be advantageous for it to spread at different 339 
sites.  340 
  341 
Conclusions: 342 
We have compelling evidence that most of the A. baumannii infections are hospital acquired 343 
especially in the ICU setting as evidenced by other studies. Due to the stringent sterilization 344 
protocols most of the clones can be eradicated, but few persistent ones remain. Although 345 
our sample size is quite low (n=17), and a single centre experience study from a single 346 
department, it shows that M13 PCR is a cost effective technique which proves to be useful for 347 
identification of clones and is slightly better than the DAF or ERIC PCR fingerprinting and 348 
standardising this method can offer an alternative and a reliable way for strain tracking in a 349 
routine lab environment which can help in prevention of further nosocomial outbreaks. 350 
Fingerprinting analyses along with MLST or indeed whole genome MLST can further aid in 351 
long term surveillance and in understanding bacterial strain evolution. Strict preventive 352 
measures that reduce transmissibility of strains, along with routine surveillance practices, 353 
can help decreasing patient morbidity and mortality and in improving antibiotic policies in 354 
the hospital which in turn can slower the evolution of more resistant organisms. 355 
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Figure Legends 509 
Figure 1: eBURST analysis for Acinetobacter baumannii obtained by comparing database STs 510 
against the studied STs (2017-08-16). 511 
 512 
Figure 2: DNA finger printing pattern obtained - using a) DAF4, b) ERIC 2 and c) M13 primer; 513 
Lane 1-17 represents isolate AB01 to AB17 respectively. 514 
 515 
